last authored: Feb 2010, David LaPierre
last reviewed:
Pneumonia, or infection of the lower respiratory tract, is one of the most important causes of death, especially during adult years. It can be caused by a number of pathogens, including bacteria, viruses, fungi, protozoans, and parasites.

normal lung on left; bronchopneumonia (arrows) on right.
courtesy of Dr Zhaolin Xu, Department of Pathology, Dalhousie University
As it is readily reversible, every health care provider should be on the lookout for it, and every physician should know how to rapidly diagnose and treat pneumonia.
Henry Chu is a
Risk factors for pneumonia include:
community-acquired in healthy adults |
|
community-acquired in elderly/ |
|
nosocomial |
|
HIV-associated |
|
alcoholic |
|
ventilator-associated |
|
immunocompromised |
|
Streptococcus pneumoniae (pneumococcus) is the most common cause of community-acquired pneumonia. It colonizes the oropharynx of up to 25% of healthy adults. Increased predisposition is seen in people with alcoholism, chronic lung disease, renal failure, sickle cell disease, prior splenectomy, hematologic malignancy, and HIV infection. Lobar consolidation with air bronchograms is typically seen by the 2nd or 3rd day of illness. In most areas of the world, penicillin G is the treatment of choice, with cephalosporins or vancomycin indicated depending on regional sensitivity patterns.
Staphylococcus aureus accounts for 2-5% of community acquired pneumonias, 11% of hospital pneumonias, and up to 26% of pneumonias following viral infection.
Haemophilus influenzae, a gram-negative coccobacillus often present in the upper respiratory tract, is especially important in people with COPD. Even though pathologic involvement therefore depends on isolation by bronchoscopy or other methods, if seen in a sputum sample, treatment should begin with ampicillin plus a beta-lactamase inhibitor, or a 2nd- or 3rd-generation cephalosporin.
Gram-negative bacilli are increasingly important lung pathogens due to use of potent antibiotics and intensive care units. They are ubiquitious throughout hospitals, contaminating equipment and instruments, and are a major source of nosocomial pneumonia. Important pathogens include klebsiella pneumoniae, Escherichia coli, Pseudomonas spp, Legionella
Other bacteria include mycoplasmal and chlamydial pneumonias
In children, viruses are the most common cause of pneumonia, with respiratory synctial virus being the most common pathogen.
Respiratory viral infection is usually limited to the upper respiratory tract, and only a small proportion of infected adults develop pneumonia.
Viral causes include:
Influenza-induced necrosis of epithelial cells predisposes to bacterial colonization, and S. pneumoniae, S. aureus, and H. influenzae pneumonias are the most common concomitant infections.
Under normal circumstances, the lungs are sterile. Pathogens can enter through inhalation, by hematogenous spread, from a contiguous focus of infection, or most commonly by aspiration of oropharyngeal secretions (almost 50% of healthy men aspirate some oropharyngeal contents during sleep). Infection can also follow inhalation of aerosolized droplets, as occurs with tuberculosis.
Defenses against pulmonary colonization include cough mucociliary clearance, and other innate immune defenses. Impaired cough reflexes (drugs, alcohol, neuromuscular disease), or impaired ciliary transport (smoking, CF, COPD) increase the likelihood of developing pneumonia.
Exudative inflammation results.
Pneumonia follows pathogen entry into the lung. Impaired normal defense mechanisms are usually required for infection to take hold.
Infection can spread along airways and through alveolar walls.
This can occur in settings of:
Lobar Pneumonia:
A thorough history and physical can help distinguish among different pathogens, but diagnostic examination can be fast and very useful.
Respiratory symptoms include:
absence of rhinorrhea or sore throat
Duration of symptoms is a critical piece of information:
A history of rhinitis or pharyngitis suggests respiratory virus, Mycoplasma, or Chlamydia. Abrupt onset of myalgia, arthralgia, headache, and fever are commonly seen in influenza virus infection.
Diarrhea suggests Legionella.
A persistent, hacking cough can be seen with Mycoplasma.
Abrupt onset of myalgias, arthralgia, headache, and fever suggest influenza or mycoplasma.
Severe pleuritic pain and/or empyema strongly suggest bacterial infection.
Confusion can suggest meningitis, seen most frequently with pneumococcus.
Most people with pneumonia have cough, fever, pleuritic chest pain, foul sputum, tachycardia, and tachypnea.
Tuberculosis can lead to high fever with few other symptoms.
Foul breath suggests anaerobes and/or lung abscess.
Confusion should immediately point to meningeal complications, or can simply represent delirium in the elderly.
Brown currant jelly sputum suggests Klebsiella
The respiratory exam can show evidence of consolidation via the following:
Increasing tachypnea, cyanosis, and use of accessory muscles for respiration suggests serious illness. Foul breath suggests anaerobic infection, ie lung abscess.
If a person presents with abrupt onset of chills, cough, pleuritic chest pain, rusty or yellow sputum, and shortness of breath, and exam shows tachypnea shows even miminal signs of pulmonary inflammation, presumptive diagnosis of bacterial pneumonia should be made, sputum should be examined, and apropriate therapy should be begun.
Emperic therapy without sputum examination is often successful, but increases in antibiotic resistance and occasional misdiagnosis, leading to increased risk of morbidity and death, mean that sputum should be Gram-stained and examined immediately.
Diagnosis is made in about 20% of patients.
blood tests
nasopharyngeal swab: influenza, parainfluenza, metapneumovirus, RSV, adenovirus
sputum smear and culture: must be done carefully to avoid contamination by oropharyngeal flora. Both false negatives and false positives are common and should be interpreted carefully.
other tests:
Chest X-rays need to be examined in the context of clinical data to successfully lead to diagnosis. A negative chest X ray can never rule out acute pneumonia if signs and symptoms point this way.
Homogenous parenchymal consolidation involving one lobe suggests bacteria.
Large pleural effusions suggest Streptococci or TB.
Mycoplasma can result in extensive infiltration on chest X-ray but scant clincial signs. Conversely, early PJP, early milliary TB, or hypersensitivity pneumonia can result in symptoms in the absence of radiographic findings.
Radiologic findings of lobar pneumonias slowly clear, suggesting 6 week interval followups.
Cavitation suggests necrotizing pneumonia, commonly seen with TB, Staph, GNRs, anaerobes, fungi, or Pneumocystis jirovecci.
The differential diagnosis of pneumonia includes:
As with any patient, it is important to begin by treating the vitals, or ABCs, of the patient. This includes, as necessary:
Guidelines for the treatment of community-acquired pneumonia are frequently updated by the Infectious Disease Society of America and the American Thoracic Society.
Empiric treatment of CAP is often successful, but using broad-spectrum antibiotics can lead to increased resistance and occasional misdiagnosis.
The Americal Academy of Emergency Physicians now recommends against routine blood cultures and early antiobiotics for presumptive CAP, before definitive clinical diagnosis is made (Nazarian et al, 2009).
In most patients, macrolides are good places to start. If a macrolide has been used in the past few months, a fluoroquinalone is the next line.
No antibiotics within past three months:
antibiotics with past three months:
no antibiotics within past three months:
antibiotics within 3 months:
a small study has recommended the addition of dexamethasone to the treatment of hospitalized patients, as this appears to decrease length of stay (Meijvis et al, 2011).
Anti-pseudomonal:
MRSA:
further gram -ve coverage
suspect aspiration (oral anerobe coverage)
ventilator-associated pneumonia
Complications include:
Increased mortality occurs in patients with:
Jung YJ, et al. 2010. Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. Crit Care Med ;38(1):175-180.
Meijvis SC et al. 2011. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia. Lancet 377(9782):2023-2030.
Nazarian et al. 2009. Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia. Ann Emerg Med. 54(5):704-731.